Blood Products & Transfusion Management
A Step 2 CK management lesson on blood products and transfusion: restrictive component thresholds and dosing effects, rapid recognition and next-best-step management of transfusion reactions (with the recurring rule to STOP the transfusion), the TACO-vs-TRALI distinction, and anticoagulation reversal.
Framing transfusion management
On Step 2 CK, transfusion questions almost always test one of three decisions: (1) which product and at what threshold, (2) recognizing a transfusion reaction and the next best step (where the near-universal first move is to STOP the transfusion), and (3) reversing anticoagulation or coagulopathy.
Modern practice is restrictive: transfuse for a physiologic need, not a number. Anchor every decision on three questions — Is this the correct product? Have I met the correct threshold? Am I watching for a reaction? Uncrossmatched emergencies get O-negative RBCs for women of childbearing potential (O-positive is acceptable for men and older women), and AB plasma is the universal-donor plasma.
- pRBCs: restrictive threshold Hgb <7 g/dL for most hospitalized/critically ill; use <8 g/dL in cardiac surgery or symptomatic CAD/ACS. One unit raises Hgb by ~1 g/dL (Hct ~3%).
- Platelets: prophylactic transfusion at <10,000/µL; ~<20,000 with fever/sepsis; <50,000 before most invasive procedures or with active bleeding; <100,000 for CNS/neurosurgery. One apheresis unit raises the count ~30–50k.
- FFP: for active bleeding with multiple factor deficiencies, massive transfusion, or urgent reversal when PCC is unavailable; dose ~10–15 mL/kg. Contains all coagulation factors and corrects the INR.
- Cryoprecipitate: give for fibrinogen <100 mg/dL with bleeding (DIC, obstetric hemorrhage); it is the concentrated source of fibrinogen, factor VIII, factor XIII, and vWF.
- ANY suspected reaction → STOP the transfusion, keep the line open with normal saline, and recheck the patient and unit identification before doing anything else.
- Give Rh-negative blood to Rh-negative girls/women of childbearing potential to prevent alloimmunization.
Blood products at a glance
| Product | Key contents | Give it for | Threshold / effect |
|---|---|---|---|
| Packed RBCs | Red cells | Symptomatic anemia, active bleeding | Hgb <7 (<8 if cardiac); 1 U ↑ Hgb ~1 g/dL |
| Platelets | Platelets | Thrombocytopenia + bleeding or pre-procedure | <10k prophylactic; <50k procedure; 1 U ↑ ~30–50k |
| FFP | All coagulation factors | Multifactor deficiency + bleeding, MTP, urgent reversal | ~10–15 mL/kg; corrects INR |
| Cryoprecipitate | Fibrinogen, VIII, XIII, vWF, fibronectin | Fibrinogen <100 (DIC, OB hemorrhage), factor XIII deficiency | Fibrinogen <100 mg/dL |
| 4-factor PCC | Factors II, VII, IX, X (+ protein C/S) | Major warfarin-associated bleeding | Faster, lower-volume than FFP |
Transfusion reactions — recognize and act
| Reaction | Cause / timing | Key clues | Next best step |
|---|---|---|---|
| Acute hemolytic (AHTR) | ABO incompatibility (clerical error); minutes, intravascular | Fever, chills, flank/back pain, hypotension, hemoglobinuria, DIC | STOP; aggressive IV normal saline to protect kidneys; return unit + sample to blood bank |
| Febrile non-hemolytic (FNHTR) | Donor cytokines/WBCs; most common reaction | Fever + chills, no hemolysis | Stop, acetaminophen; prevent with leukoreduction |
| Allergic (urticarial) | Plasma proteins | Hives, pruritus, no instability | Pause; antihistamine; may resume if mild and resolves |
| Anaphylaxis | IgA deficiency (anti-IgA antibodies) | Hypotension, wheeze, angioedema | Stop; epinephrine; use washed / IgA-deficient products |
| TRALI | Donor anti-leukocyte antibodies; <6 hr | Hypoxia, bilateral infiltrates, normal JVP/BNP | Stop; supportive respiratory / O2 support (no diuresis) |
| TACO | Volume overload; during/after | Dyspnea, HTN, JVD, ↑BNP, edema | Slow/stop; IV furosemide, sit upright, O2 |
| Bacterial / septic | Contamination (platelets, stored at room temp) | High fever, rigors, shock | Stop; cultures + broad-spectrum antibiotics |
A 54-year-old woman receiving her first unit of packed RBCs for anemia from a GI bleed develops fever to 38.9°C, rigors, back pain, and hypotension (BP 88/50) about 15 minutes into the transfusion. Her urine in the Foley bag now appears pink.
Next best step: Immediately STOP the transfusion. Disconnect the tubing, keep the IV line open with normal saline, and send the unit plus a fresh post-transfusion blood sample back to the blood bank while rechecking the patient's and unit's identification. Then give aggressive IV crystalloid to maintain urine output and protect the kidneys.
This is an acute hemolytic transfusion reaction from ABO incompatibility — almost always a clerical/identification error. Do not merely slow the rate or give an antipyretic: the answer is to stop completely and support the kidneys.
An 80-year-old man with CKD and heart failure becomes dyspneic 2 hours into his second unit of packed RBCs. Exam: BP 192/96, JVD, bibasilar crackles, an S3; BNP markedly elevated; CXR shows bilateral infiltrates with cardiomegaly.
Next best step: This is TACO (transfusion-associated circulatory overload) — slow or stop the transfusion, give IV furosemide, sit the patient upright, and provide supplemental oxygen.
Contrast: If the same patient were hypotensive with no JVD, a normal BNP, and new hypoxemia with bilateral infiltrates within 6 hours, the diagnosis is TRALI — managed with supportive respiratory care (often mechanical ventilation) and NOT diuresis. TACO and TRALI are the two leading causes of transfusion-related death — by current FDA fatality data TACO is now the most commonly reported, with TRALI historically the top cause and still a major one. Distinguishing them hinges on volume-status clues (JVD, BP, BNP).
Reversing anticoagulation / coagulopathy
| Agent to reverse | Reversal | Notes |
|---|---|---|
| Warfarin — major bleed | 4-factor PCC + IV vitamin K 10 mg | FFP only if PCC unavailable |
| Warfarin — high INR, no bleed | Hold dose ± oral vitamin K | Do not use PCC/FFP |
| Heparin (UFH) | Protamine sulfate | Only partial reversal of LMWH |
| Dabigatran | Idarucizumab | Direct thrombin inhibitor |
| Rivaroxaban / apixaban | Andexanet alfa (or 4F-PCC) | Factor Xa inhibitors |
| tPA-associated bleed | Cryoprecipitate (± antifibrinolytic) | Replaces consumed fibrinogen |
TACO = Transfusion-Associated Circulatory Overload. Picture eating too many tacos → overloaded and full → hypertensive, JVD, elevated BNP → the fix is a diuretic (furosemide).
TRALI = Transfusion-Related Acute Lung Injury. The L is for Lung → a hypoxic lung problem with normal volume status → the fix is respiratory support, not a diuretic.
Cryo contents: remember cryoprecipitate carries factors 1, 8, 13 (fibrinogen, VIII, XIII) + vWF + fibronectin — the go-to product when fibrinogen is low.
- Leukoreduction reduces FNHTR, CMV transmission, and HLA alloimmunization → use leukoreduced/CMV-safe products.
- Irradiation prevents transfusion-associated GVHD — required for the immunocompromised, stem-cell transplant recipients, neonates, and directed donations from blood relatives.
- Washed (plasma-depleted) products are for IgA deficiency or recurrent severe allergic/anaphylactic reactions.
- Massive transfusion protocol: replace in a ~1:1:1 ratio of RBC : FFP : platelets. Watch for citrate-induced hypocalcemia (give calcium), hyperkalemia, hypothermia (use a warmer), and dilutional coagulopathy.
- Common pitfalls: transfusing to a target Hgb >7–8 without symptoms, slowing rather than stopping a suspected AHTR, and diuresing TRALI as if it were TACO.
Practice Clinical Management now
Board-style questions, spaced-repetition flashcards, and a Socratic AI tutor — free to start.